July
21, 2006
MDA
Clinician, Researcher,
Board Member Receives Award
Neurologist and neuromuscular disease
specialist Stanley Appel, a long-time
MDA research grantee and clinician,
as well as an MDA Board member, has
been named the recipient of the Peggy
and Gary Edwards Distinguished Endowed
Chair for the Treatment and Research
of Amyotrophic Lateral Sclerosis (ALS),
a devastating neurological disorder.
“I think this award truly recognizes
Dr. Appel’s accomplishments,
from the establishment of his first
rate multidisciplinary clinic for
ALS care, to his long and productive
career in ALS research,” said
Sharon Hesterlee, MDA director of
Research Development.
Gary Edwards, a board member at Methodist
Hospital in Houston, where Appel practices,
and his wife, Peggy Edwards, established
the $1 million endowed chair for a
physician-scientist who champions
the research and treatment of patients
with ALS, or Lou Gehrig’s disease.
Gary’s mother, Jeannette, who
died in 1985, had ALS and was cared
for by Appel in the 1980s.
Appel is chairman of neurology and
co-founder of the Methodist Neurological
Institute, where he’s also director
of the MDA/ALS Center and co-director
of the MDA Neuromuscular Clinic.
ALS is a devastating neuromuscular
disease that causes progressive paralysis
of voluntary muscles, including those
controlling breathing, by mysteriously
destroying the nerve cells in the
brain and spinal cord that control
them.
Current treatments are aimed at symptom
relief and prolongation of life. The
cause of the disease remains unknown
for the vast majority of cases, although
a small percentage of cases have a
clear-cut genetic origin.
Appel’s current research grant
with MDA is for the study of immunologic
mechanisms in ALS.
“I’m grateful to Mr.
and Mrs. Edwards for honoring our
MDA/ALS team at the Methodist Hospital,”
Appel said, “and for supporting
our collective efforts to improve
the quality of life for our patients.
“Mr. Edwards’ mother,
Jeannette, was one of the beneficiaries
of our MDA clinical programs and,
since those early days, we’ve
made significant progress. We truly
appreciate the generosity of the Edwards
family and their encouragement of
our ability to make a difference in
the lives of our courageous ALS patients.”
|